UniProt ID | ADIP_HUMAN | |
---|---|---|
UniProt AC | Q9Y2D8 | |
Protein Name | Afadin- and alpha-actinin-binding protein | |
Gene Name | SSX2IP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 614 | |
Subcellular Localization | Cell junction, adherens junction. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite . Cytoplasm, cytoskeleton, cilium basal body . Not found at cell-matrix AJs.. | |
Protein Description | Belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). May connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin (By similarity). Involved in cell movement: localizes at the leading edge of moving cells in response to PDGF and is required for the formation of the leading edge and the promotion of cell movement, possibly via activation of Rac signaling (By similarity). Acts as a centrosome maturation factor, probably by maintaining the integrity of the pericentriolar material and proper microtubule nucleation at mitotic spindle poles. The function seems to implicate at least in part WRAP73; the SSX2IP:WRAP73 complex is proposed to act as regulator of spindle anchoring at the mitotic centrosome. [PubMed: 23816619] | |
Protein Sequence | MGDWMTVTDPGLSSESKTISQYTSETKMSPSSLYSQQVLCSSIPLSKNVHSFFSAFCTEDNIEQSISYLDQELTTFGFPSLYEESKGKETKRELNIVAVLNCMNELLVLQRKNLLAQENVETQNLKLGSDMDHLQSCYSKLKEQLETSRREMIGLQERDRQLQCKNRNLHQLLKNEKDEVQKLQNIIASRATQYNHDMKRKEREYNKLKERLHQLVMNKKDKKIAMDILNYVGRADGKRGSWRTGKTEARNEDEMYKILLNDYEYRQKQILMENAELKKVLQQMKKEMISLLSPQKKKPRERVDDSTGTVISDVEEDAGELSRESMWDLSCETVREQLTNSIRKQWRILKSHVEKLDNQVSKVHLEGFNDEDVISRQDHEQETEKLELEIQQCKEMIKTQQQLLQQQLATAYDDDTTSLLRDCYLLEEKERLKEEWSLFKEQKKNFERERRSFTEAAIRLGLERKAFEEERASWLKQQFLNMTTFDHQNSENVKLFSAFSGSSDWDNLIVHSRQPQKKPHSVSNGSPVCMSKLTKSLPASPSTSDFCQTRSCISEHSSINVLNITAEEIKPNQVGGECTNQKWSVASRPGSQEGCYSGCSLSYTNSHVEKDDLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 3) | Phosphorylation | - | 36.97 | 24719451 | |
4 (in isoform 3) | Phosphorylation | - | 4.42 | 27251275 | |
6 | Phosphorylation | --MGDWMTVTDPGLS --CCCCCCCCCCCCC | 18.92 | 29759185 | |
8 | Phosphorylation | MGDWMTVTDPGLSSE CCCCCCCCCCCCCCC | 27.58 | 29759185 | |
16 | Phosphorylation | DPGLSSESKTISQYT CCCCCCCCCCHHHHC | 36.73 | 29759185 | |
18 | Phosphorylation | GLSSESKTISQYTSE CCCCCCCCHHHHCCC | 34.83 | - | |
29 | Phosphorylation | YTSETKMSPSSLYSQ HCCCCCCCHHHHHHC | 24.16 | 29978859 | |
31 | Phosphorylation | SETKMSPSSLYSQQV CCCCCCHHHHHHCHH | 26.18 | 29978859 | |
32 | Phosphorylation | ETKMSPSSLYSQQVL CCCCCHHHHHHCHHH | 34.41 | 29978859 | |
34 | Phosphorylation | KMSPSSLYSQQVLCS CCCHHHHHHCHHHHC | 13.33 | 27251275 | |
35 | Phosphorylation | MSPSSLYSQQVLCSS CCHHHHHHCHHHHCC | 21.30 | 29978859 | |
112 (in isoform 1) | Ubiquitination | - | 38.70 | 21890473 | |
112 | Ubiquitination | ELLVLQRKNLLAQEN HHHHHHHHHHHHHCC | 38.70 | 21890473 | |
112 | Ubiquitination | ELLVLQRKNLLAQEN HHHHHHHHHHHHHCC | 38.70 | 21890473 | |
112 (in isoform 2) | Ubiquitination | - | 38.70 | 21890473 | |
126 | Ubiquitination | NVETQNLKLGSDMDH CHHHCCCCCCCCHHH | 59.35 | - | |
129 | Phosphorylation | TQNLKLGSDMDHLQS HCCCCCCCCHHHHHH | 39.95 | 26552605 | |
136 | Phosphorylation | SDMDHLQSCYSKLKE CCHHHHHHHHHHHHH | 22.76 | 26552605 | |
138 | Phosphorylation | MDHLQSCYSKLKEQL HHHHHHHHHHHHHHH | 17.68 | 26552605 | |
139 | Phosphorylation | DHLQSCYSKLKEQLE HHHHHHHHHHHHHHH | 35.52 | 26552605 | |
142 | Ubiquitination | QSCYSKLKEQLETSR HHHHHHHHHHHHHHH | 47.34 | - | |
174 | Ubiquitination | RNLHQLLKNEKDEVQ CCHHHHHHCCHHHHH | 72.20 | - | |
182 | Ubiquitination | NEKDEVQKLQNIIAS CCHHHHHHHHHHHHH | 58.16 | - | |
192 | Phosphorylation | NIIASRATQYNHDMK HHHHHHHHHCHHHHH | 30.40 | 25003641 | |
219 | Ubiquitination | LHQLVMNKKDKKIAM HHHHHCCCCCHHHHH | 44.23 | - | |
231 | Phosphorylation | IAMDILNYVGRADGK HHHHHHHHHHCCCCC | 10.80 | 23403867 | |
257 | Ubiquitination | RNEDEMYKILLNDYE CCHHHHHHHHHCCHH | 26.10 | - | |
268 | Ubiquitination | NDYEYRQKQILMENA CCHHHHHHHHHHHHH | 30.24 | - | |
290 | Phosphorylation | QMKKEMISLLSPQKK HHHHHHHHHHCCCCC | 23.19 | 30266825 | |
293 | Phosphorylation | KEMISLLSPQKKKPR HHHHHHHCCCCCCCC | 30.49 | 30266825 | |
306 | Phosphorylation | PRERVDDSTGTVISD CCHHCCCCCCCEEEC | 25.03 | 29255136 | |
307 | Phosphorylation | RERVDDSTGTVISDV CHHCCCCCCCEEECH | 43.81 | 29255136 | |
309 | Phosphorylation | RVDDSTGTVISDVEE HCCCCCCCEEECHHH | 18.11 | 29255136 | |
312 | Phosphorylation | DSTGTVISDVEEDAG CCCCCEEECHHHHHC | 31.13 | 19664994 | |
322 | Phosphorylation | EEDAGELSRESMWDL HHHHCCCCHHHHHHH | 29.69 | 28176443 | |
325 | Phosphorylation | AGELSRESMWDLSCE HCCCCHHHHHHHCHH | 24.86 | 22817900 | |
339 | Phosphorylation | ETVREQLTNSIRKQW HHHHHHHHHHHHHHH | 26.98 | 19691289 | |
341 | Phosphorylation | VREQLTNSIRKQWRI HHHHHHHHHHHHHHH | 20.66 | 25159151 | |
350 | Ubiquitination | RKQWRILKSHVEKLD HHHHHHHHHHHHHHH | 35.82 | - | |
351 | Phosphorylation | KQWRILKSHVEKLDN HHHHHHHHHHHHHHH | 29.35 | 28102081 | |
355 | Ubiquitination | ILKSHVEKLDNQVSK HHHHHHHHHHHCCEE | 61.11 | - | |
362 (in isoform 1) | Ubiquitination | - | 34.51 | 21890473 | |
362 | Ubiquitination | KLDNQVSKVHLEGFN HHHHCCEEEHHCCCC | 34.51 | 21906983 | |
362 (in isoform 2) | Ubiquitination | - | 34.51 | 21890473 | |
394 | Ubiquitination | ELEIQQCKEMIKTQQ HHHHHHHHHHHHHHH | 46.08 | - | |
398 (in isoform 2) | Ubiquitination | - | 38.68 | 21890473 | |
398 | Ubiquitination | QQCKEMIKTQQQLLQ HHHHHHHHHHHHHHH | 38.68 | 21906983 | |
398 (in isoform 1) | Ubiquitination | - | 38.68 | 21890473 | |
418 | Phosphorylation | AYDDDTTSLLRDCYL HCCCCHHHHHHHHHH | 27.74 | 24719451 | |
429 | Ubiquitination | DCYLLEEKERLKEEW HHHHHHHHHHHHHHH | 38.47 | - | |
433 | Ubiquitination | LEEKERLKEEWSLFK HHHHHHHHHHHHHHH | 60.86 | - | |
437 | Phosphorylation | ERLKEEWSLFKEQKK HHHHHHHHHHHHHHH | 27.49 | 24719451 | |
440 | Ubiquitination | KEEWSLFKEQKKNFE HHHHHHHHHHHHHHH | 65.61 | - | |
452 | Phosphorylation | NFERERRSFTEAAIR HHHHHHHHHHHHHHH | 42.62 | 21712546 | |
454 | Phosphorylation | ERERRSFTEAAIRLG HHHHHHHHHHHHHHC | 26.43 | 19691289 | |
476 (in isoform 1) | Ubiquitination | - | 35.48 | 21890473 | |
476 | Ubiquitination | EERASWLKQQFLNMT HHHHHHHHHHHHCCC | 35.48 | 21890473 | |
476 | Ubiquitination | EERASWLKQQFLNMT HHHHHHHHHHHHCCC | 35.48 | 21890473 | |
476 (in isoform 2) | Ubiquitination | - | 35.48 | 21890473 | |
483 | Phosphorylation | KQQFLNMTTFDHQNS HHHHHCCCCCCCCCC | 24.20 | 28111955 | |
484 | Phosphorylation | QQFLNMTTFDHQNSE HHHHCCCCCCCCCCC | 19.12 | 28111955 | |
490 | Phosphorylation | TTFDHQNSENVKLFS CCCCCCCCCCEEEEE | 24.79 | 28111955 | |
500 | Phosphorylation | VKLFSAFSGSSDWDN EEEEEECCCCCCCCC | 37.17 | 23186163 | |
502 | Phosphorylation | LFSAFSGSSDWDNLI EEEECCCCCCCCCEE | 24.75 | 23186163 | |
503 | Phosphorylation | FSAFSGSSDWDNLIV EEECCCCCCCCCEEE | 46.36 | 23186163 | |
521 | Phosphorylation | QPQKKPHSVSNGSPV CCCCCCCCCCCCCCC | 35.45 | 27251275 | |
523 | Phosphorylation | QKKPHSVSNGSPVCM CCCCCCCCCCCCCCH | 38.19 | 24719451 | |
526 | Phosphorylation | PHSVSNGSPVCMSKL CCCCCCCCCCCHHHH | 20.57 | 28985074 | |
534 | Phosphorylation | PVCMSKLTKSLPASP CCCHHHHCCCCCCCC | 23.48 | 30624053 | |
535 | Ubiquitination | VCMSKLTKSLPASPS CCHHHHCCCCCCCCC | 61.50 | - | |
536 | Phosphorylation | CMSKLTKSLPASPST CHHHHCCCCCCCCCC | 34.06 | 25159151 | |
540 | Phosphorylation | LTKSLPASPSTSDFC HCCCCCCCCCCCHHH | 19.90 | 25159151 | |
542 | Phosphorylation | KSLPASPSTSDFCQT CCCCCCCCCCHHHCC | 37.74 | 22617229 | |
543 | Phosphorylation | SLPASPSTSDFCQTR CCCCCCCCCHHHCCH | 35.38 | 27794612 | |
544 | Phosphorylation | LPASPSTSDFCQTRS CCCCCCCCHHHCCHH | 32.78 | 27794612 | |
549 | Phosphorylation | STSDFCQTRSCISEH CCCHHHCCHHHHCCC | 26.23 | 20068231 | |
565 | Phosphorylation | SINVLNITAEEIKPN CEEEEEEEHHHCCCC | 27.26 | 19007248 | |
582 | Acetylation | GGECTNQKWSVASRP CCCCCCCCCEEECCC | 43.43 | 10652607 | |
584 | Phosphorylation | ECTNQKWSVASRPGS CCCCCCCEEECCCCC | 18.16 | 27251275 | |
587 | Phosphorylation | NQKWSVASRPGSQEG CCCCEEECCCCCCCC | 36.53 | 30576142 | |
591 | Phosphorylation | SVASRPGSQEGCYSG EEECCCCCCCCCCCC | 27.95 | 30576142 | |
596 | Phosphorylation | PGSQEGCYSGCSLSY CCCCCCCCCCCCCEE | 20.96 | 26471730 | |
597 | Phosphorylation | GSQEGCYSGCSLSYT CCCCCCCCCCCCEEC | 37.08 | 28985074 | |
600 | Phosphorylation | EGCYSGCSLSYTNSH CCCCCCCCCEECCCC | 24.71 | 29449344 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ADIP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ADIP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ADIP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-536 ANDSER-540, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-339; SER-341; SER-540AND THR-565, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293 AND SER-325, ANDMASS SPECTROMETRY. |